tiprankstipranks
HilleVax announces executive management appointments, promotions
The Fly

HilleVax announces executive management appointments, promotions

HilleVax (HLVX) announced the appointment of Ozzie Berger as Senior Vice President of Regulatory Affairs, the promotion of Anju Chatterji to Chief Technical Officer, and the promotion of Shane Maltbie to Chief Financial Officer. As part of a planned transition in connection with Maltbie’s promotion, David Socks will focus on business development activities as the company’s Chief Business Officer. Berger brings to HilleVax nearly three decades of expertise in creating and implementing innovative regulatory strategies across all phases of product development and commercialization. Prior to joining HilleVax, Berger was Vice President and Global Regulatory Head for GSK‘s (GSK) Vaccine Therapeutic Group. Dr. Chatterji has more than 20 years of experience implementing CMC development and manufacturing strategies to drive successful global regulatory filings and approvals. She served as Senior Vice President of Technical Operations for HilleVax since joining the company in January 2022. Maltbie was previously Vice President of Finance at HilleVax and has two decades of experience in finance operations, including building and leading multiple finance organizations.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on HLVX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles